Lyell Competitors and Similar CompaniesClear all
Arvinas's competitors and similar companies include Agenus.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New Haven, US HQ | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US |
Employees | Employees 13329% increase | Employees 8174% decrease |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 96.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) $114.2m (FY, 2025) |
Net income | Net income ($80.8m) (FY, 2025) | Net income ($3.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 111.6m | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View Company Profiles
Agenus
HQ
Lexington, US
Employees
81
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company